THOMPSON SIEGEL & WALMSLEY LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$2
-100.0%
22
-100.0%
0.00%
-100.0%
Q3 2022$12,829,000
-19.0%
173,290
-28.7%
0.22%
-12.9%
Q2 2022$15,840,000
-10.2%
243,013
-12.9%
0.26%
+1.6%
Q1 2022$17,647,000
+15.2%
279,142
-3.4%
0.25%
+19.0%
Q4 2021$15,322,000
-10.2%
288,873
+19.5%
0.21%
-14.2%
Q3 2021$17,066,000
-20.1%
241,763
-24.5%
0.25%
-15.8%
Q2 2021$21,352,000
+1067500.0%
320,413
+533921.7%
0.29%
Q4 2016$2,000600.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders